고마바이오텍(주)
Category 전체보기
전기영동 > 단백질 전기영동 전기영동 > 헥산 전기영동
Cat. No.전체보기

검색 결과가 없습니다.

Product전체보기

검색 결과가 없습니다.

Brand전체보기

검색 결과가 없습니다.

제품 상세

Antibody

6.5 - 270 kDa 범위를 커버하는 3가지 컬러 밴드를 포함하며,
최대 100%까지의 transfer 효과를 개런티하는 Prestained protein ladder를 소개합니다.

특징 

 

  • 항체약물은 4세대를 거쳐 진화해 왔습니다. 1세대는 mouse antibody, 2세대는 human-mouse chimeric antibody, 3세대는 humanized antibody, 4세대는 완전한 human antibody 입니다. 항체약물의 작용 기전은 일반적으로 세포독성약물, 세포증식억제, 세포활성화 및 상호작용조절, 인간면역체계조절, 항원 중화등에 관여합니다. 
  • 항체약물은 암 및 자가면역질환, 안과질환, 고지혈증, 골다공증, 천식, 다발성경화증과 같은 많은 영역에 적용되고 있습니다. 
  • 연구 등급 바이오시밀러 항체는 치료용 mAb를 모방한 mAb 연구 및, 이러한 치료제의 생물학적 효과를 탐구하고, 새로운 치료법을 연구하고, 효과적인 표적 외 응용 분야를 밝혀내기 위한 도구로 사용됩니다.
  • 모든 항체는 95% 이상의 purity를 제공합니다. 
  • 연구분야 
    • Cancer
    • Neurodegenerative Disease
    • Inflammatory Diseases
    • Autoimmune Disorders – Rheumatoid Arthritis, Crohn’s, Diabetes
    • Pain
    • Asthma
    • Infection

 

 

주요 제품

 

1) Immunecheck point 

 

Target Cat. No. Product  Immunogen
PD-L1/CD274 10-672 Avelumab (CD274/B7-H1/PDL1) Homo sapiens / CD274/B7-H1/PDL1 [Homo sapiens]
10-678 Atezolizumab (CD274/B7-H1/PDL1) Humanized / CD274/B7-H1/PDL1 [Homo sapiens]
10-680 Durvalumab (CD274/B7-H1/PDL1) Homo sapiens / CD274/B7-H1/PDL1 [Homo sapiens]
PD-1/PDCD-1/CD279 10-834 Gilvetmab (PDCD1/PD1/CD279) Caninized / PDCD1/PD1/CD279 [Canis lupus familiaris]
10-906 Budigalimab (PDCD1/PD1/CD279) Chimeric,Humanized / PDCD1/PD1/CD279 [Homo sapiens]
10-916 Prolgolimab (PDCD1/PD1/CD279) Homo sapiens,Chimeric / PDCD1/PD1/CD279 [Homo sapiens]
LAG-3 10-951 Ieramilimab (LAG3 ) Humanized / LAG3 [Homo sapiens]
10-977 Encelimab (LAG3/CD223) Humanized / LAG3/CD223 [Homo sapiens]
10-979 Fianlimab (LAG3/CD223) Homo sapiens / LAG3/CD223 [Homo sapiens]
CTLA4 10-948 Zalifrelimab (CTLA4/CD152) Homo sapiens / CTLA4/CD152 [Homo sapiens]
10-214 Ipilimumab (CTLA4/CD152) Homo sapiens / CTLA4/CD152 [Homo sapiens]
10-266 Tremelimumab (CTLA4/CD152) Homo sapiens / CTLA4/CD152 [Homo sapiens]
B7-H3 10-987 Mirzotamab (CD276/B7-H3) Chimeric,Humanized / CD276/B7-H3 [Homo sapiens]
10-915 Omburtamab (CD276/B7-H3/B7RP-2) Mus musculus / CD276/B7-H3/B7RP-2 [Homo sapiens]
TIGIT 10-856 Tiragolumab (TIGIT/VSIG9/VSTM3) Homo sapiens / TIGIT/VSIG9/VSTM3 [Homo sapiens]
10-885 Etigilimab (TIGIT/VSTM3) Humanized / TIGIT/VSTM3 [Homo sapiens]
11-005 Vibostolimab (TIGIT/VSIG9/VSTM3) Humanized / TIGIT/VSIG9/VSTM3 [Homo sapiens]
ICOS 10-883 Vopratelimab (ICOS/CD278) Humanized / ICOS/CD278 [Homo sapiens]

 


   

  

  

2) Cluster of Differentiation (CD) 

 

Target Cat. No. Product  Immunogen
CD 10-690 Isatuximab (CD38) Chimeric / CD38 [Homo sapiens]
10-176 ICM3 (CD50) Chimeric,Humanized / CD50 [Homo sapiens]
10-655 Coltuximab Ravtansine (CD19 ) Chimeric / CD19 [Homo sapiens]


3) Growth Factors & Receptors

Target Cat. No. Product  Immunogen
Growth factor 10-189 Ganitumab (IGF1R/CD221) Homo sapiens / IGF1R/CD221 [Homo sapiens]
10-499 Parsatuzumab (EGFL7) Humanized / EGFL7 [Homo sapiens]


4) Neurodegeneration

Target Cat. No. Product  Immunogen
Alzheimers 10-629 Aducanumab (APP  Abeta) Homo sapiens / APP Abeta [Homo sapiens]
10-244 Gantenerumab (APP /Abeta42/Abeta40) Homo sapiens / APP /Abeta42/Abeta40 [Homo sapiens]
Multiple Sclerosis (MS) 10-215 J695 (IL12A/CD18) Homo sapiens,Humanized / IL12A/CD18 [Homo sapiens]
10-193 Ustekinumab (IL12B) Homo sapiens / IL12B [Homo sapiens]
Parkinsons 10-962 Cinpanemab (SNCA ) Humanized / SNCA [Homo sapiens]
10-860 Prasinezumab (SNCA) Humanized / SNCA [Homo sapiens]



5) Autoimmunity, Inflammation & Pain

Target Cat. No. Product  Immunogen
Diabetes 10-734 Plozalizumab (CCR2/CD192) Humanized / CCR2/CD192 [Homo sapiens]
10-945 Volagidemab (GCGR) Homo sapiens / GCGR [Homo sapiens]
Rheumatoid Arthritis  10-336 Fezakinumab (IL22) Homo sapiens / IL22 [Homo sapiens]
10-847 Gimsilumab (CSF2 /GM-CSF) Homo sapiens / CSF2 /GM-CSF [Homo sapiens]
10-177 Infliximab (TNF-alpha) Chimeric / TNF-alpha [Homo sapiens]
Lupus 10-340 Rontalizumab (IFNA1) Humanized / IFNA1 [Homo sapiens]
10-624 Anifrolumab (IFNAR1) Homo sapiens / IFNAR1 [Homo sapiens]
10-282 Belimumab (TNFSF13B/CD257) Homo sapiens / TNFSF13B/CD257 [Homo sapiens]
Crohns & IBS 10-832 Selicrelumab (CD40/TNFRSF5) Homo sapiens / CD40/TNFRSF5 [Homo sapiens]
10-893 Mitazalimab (CD40/TNFRSF5) Humanized / CD40/TNFRSF5 [Homo sapiens]
10-458 Tregalizumab (CD4) Humanized / CD4 [Homo sapiens]
Asthma 10-141 Campath-9H (CD4) Mus musculus,Humanized / CD4 [Homo sapiens]
10-178 Keliximab (CD4) Chimeric / CD4 [Homo sapiens]
10-188 Al-901 (IGHE) Homo sapiens / IGHE [Homo sapiens]



6) Infectious Disease

Target Cat. No. Product  Immunogen
Viral Infections 10-671 Firivumab (Influenza A virus hemagglutinin HA) Homo sapiens / Influenza A virus hemagglutinin HA [Influenza A virus]
10-828 Gedivumab (Influenza A virus hemagglutinin HA) Homo sapiens / Influenza A virus hemagglutinin HA [Influenza A virus]
10-698 Navivumab (Influenza A virus hemagglutinin HA) Homo sapiens / Influenza A virus hemagglutinin HA [Influenza A virus]
Bacterial Infections 10-596 Tosatoxumab (alpha toxin) Homo sapiens / alpha toxin [Staphylococcus aureus]
10-854 Atidortoxumab (alpha toxin) Homo sapiens / alpha toxin [Staphylococcus aureus];bi-component leukocidins [Staphylococcus aureus]
10-277 Raxibacumab (Anthrax protective antigen ) Homo sapiens / Anthrax protective antigen [Bacillus anthracis]



 

Biosimilar Monoclonal Antibody List  

 

Cat. No. Product Name Immunogen Isotype
10-134 14F7 (ganglioside N-glycolyl GM3) Mus musculus / ganglioside N-glycolyl GM3 [Homo sapiens] IgG1-kappa
10-137 Abagovomab (idiotope of anti-Mus musculus monoclonal antibody OC126) Mus musculus / idiotope of anti- Mus musculus monoclonal antibodyOC126 [Homo sapiens] IgG1-kappa
10-167 Abciximab (ITGA2B_ITGB3) Chimeric / ITGA2B_ITGB3 [Homo sapiens] Fab-G1-kappa
10-905 Abelacimab (F11) Homo sapiens / F11 [Homo sapiens] IgG1-lambda
10-654 Abituzumab (ITGAV /CD51) Humanized / ITGAV /CD51 [Homo sapiens] IgG2-kappa
10-886 Abrezekimab (IL13) Humanized / IL13 [Homo sapiens] Fab-G1-kappa
10-660 Abrilumab (ITGA4_ITGB7) Homo sapiens / ITGA4_ITGB7 [Homo sapiens] IgG2-kappa
10-184 ABX-IL8 (IL8) Homo sapiens / IL8 [Homo sapiens] IgG2-nd
21-881 Acapatamab Chimeric, Humanized / FOLH1, CD3E Bispecific scFv;Kappa;Lambda
21-882 Acasunlimab Humanized / CD274, TNFRSF9 Bispecific IgG1;Lambda;Kappa
10-483 Actoxumab (toxin A) Homo sapiens / toxin A [Clostridium difficile] IgG1-kappa
10-186 Adalimumab (TNFSF2/TNF-alpha/TNFA) Homo sapiens / TNFSF2/TNF-alpha/TNFA [Homo sapiens] IgG1-kappa
10-185 Adecatumumab (EPCAM) Homo sapiens / EPCAM [Homo sapiens] IgG1-nd
10-629 Aducanumab (APP  Abeta) Homo sapiens / APP Abeta [Homo sapiens] IgG1-kappa
10-744 Afasevikumab (IL17A /IL17F) Homo sapiens / IL17A /IL17F [Homo sapiens] IgG1-kappa
21-879 Aflibercept Humanized / VEGFA [Homo sapiens] Human IgG1
10-188 Al-901 (IGHE) Homo sapiens / IGHE [Homo sapiens]  
10-255 Alacizumab (KDR/VEGFR2/CD309) Humanized / KDR/VEGFR2/CD309 [Homo sapiens] di-Fab'
10-049 Alemtuzumab (CD52) Humanized / CD52 [Homo sapiens] IgG1-kappa
10-168 Alg-991 (Urushiol) Chimeric / Urushiol [Toxicodendron] IgM-nd
10-485 Alirocumab (PCSK9) Homo sapiens / PCSK9 [Homo sapiens] IgG1-kappa
21-884 Alnuctamab Humanized / TNFRSF17, CD3E Bispecific ,IgG1;IgG1,Kappa;Lambda
21-883 Alomfilimab Homo sapiens / ICOS IgG1,Kappa
24-390 alpha 5 beta 1 Integrin Antibody [M200 (Volociximab)], Human IgG4 Heterodimeric α5β1Fc
fusion protein
IgG4 kappa
24-391 alpha 5 beta 1 Integrin Antibody [M200 (Volociximab)], Rabbit IgG Heterodimeric α5β1Fc
fusion protein
IgG kappa
10-327 Altumomab (CEACAM5/CD66e) Mus musculus / CEACAM5/CD66e [Homo sapiens] IgG1-nd
10-086 Amatuximab (MSLN) Chimeric / MSLN [Homo sapiens] IgG1-kappa
10-966 Amivantamab (EGFR/ME/RCCP2) Homo sapiens / EGFR/ME/RCCP2 [Homo sapiens] IgG1-kappa
21-885 Amlitelimab Humanized / TNFSF4 IgG4,Kappa
10-298 Anatumomab Mafenatox (TAG-72) Mus musculus / TAG-72 [Homo sapiens] Fab-G1-kappa
21-886 Anbenitamab Humanized / ERBB2 (Domain II), ERBB2 (Domain IV) Bispecific ,IgG1;Kappa;Kappa
10-684 Andecaliximab (MMP9) Chimeric / MMP9 [Homo sapiens] IgG4-kappa
10-614 Anetumab Ravtansine (MSLN) Homo sapiens / MSLN [Homo sapiens] IgG1-lambda
10-624 Anifrolumab (IFNAR1) Homo sapiens / IFNAR1 [Homo sapiens] IgG1-kappa
10-253 Anrukinzumab (IL13) Humanized / IL13 [Homo sapiens] IgG1-kappa
21-872 Ansuvimab Humanized / GP1 surface protein of Ebolavirus IgG1 
21-877 Anti CD146/MUC18 (c3.19.1) Humanized / CD146/MUC18 [Homo sapiens] Human IgG2 
21-876 Anti IL1RL1/ST2 (STLM208) Humanized / IL1RL1/ST2 [Homo sapiens] Human IgG
21-875 Anti IL1RL1/ST2(C2244) Humanized / IL1RL1/ST2 [Homo sapiens] Human IgG
21-863 Anti NS1 of dengue virus Humanized / Dengue virus Human IgG1
21-861 Anti-CD28 Humanized / CD28 (Tp44) [Homo sapiens] Human IgG4
21-860 Anti-CLDN18.2   Mouse IgG1
21-862 Anti-LGR4 Humanized / LGR4 ( G protein-coupled receptor 48, G protein-coupled receptor GPR48, G-protein coupled receptor 48, leucine-rich repeat containing G protein-coupled receptor 4, Leucine-rich repeat-containing G-protein coupled receptor 4) [Homo sapiens] Human IgG1
10-067 Apolizumab (HLA-DRB) Humanized / HLA-DRB [Homo sapiens] IgG1-nd
10-794 Aprutumab (FGFR2) Homo sapiens / FGFR2 [Homo sapiens] IgG1-lambda
10-139 Arcitumomab (CEACAM5/CD66e) Mus musculus / CEACAM5/CD66e [Homo sapiens] Fab'-G1-nd
10-730 Ascrinvacumab (ACVRL1/SKR3/TGF-B/ TSR-I) Homo sapiens / ACVRL1/SKR3/TGF-B/ TSR-I [Homo sapiens] IgG2-kappa
10-287 Aselizumab (SELL/CD62L ) Humanized / SELL/CD62L [Homo sapiens] IgG4-nd
10-968 Astegolimab (IL1RL1) Homo sapiens / IL1RL1 [Homo sapiens] IgG2-kappa
10-678 Atezolizumab (CD274/B7-H1/PDL1) Humanized / CD274/B7-H1/PDL1 [Homo sapiens] IgG1-kappa
10-854 Atidortoxumab (alpha toxin) Homo sapiens / alpha toxin [Staphylococcus aureus];bi-component leukocidins [Staphylococcus aureus] IgG1-kappa
10-445 Atinumab (RTN4/NOGO) Homo sapiens / RTN4/NOGO [Homo sapiens] IgG4-kappa
10-959 Atoltivimab (Zaire Ebola virus) Homo sapiens / Zaire Ebola virus [Zaire ebolavirus] IgG1-kappa
10-969 Avdoralimab (C5AR1) Homo sapiens / C5AR1 [Homo sapiens] IgG1-kappa
10-672 Avelumab (CD274/B7-H1/PDL1) Homo sapiens / CD274/B7-H1/PDL1 [Homo sapiens] IgG1-lambda
10-970 Avizakimab (IL21) Humanized / IL21 [Homo sapiens] IgG1-kappa
10-971 Axatilimab (CSF1R/CD115) Humanized / CSF1R/CD115 [Homo sapiens] IgG4-kappa
10-829 Azintuxizumab (SLAMF7/CRACC/CD319) Chimeric,Humanized / SLAMF7/CRACC/CD319 [Homo sapiens] IgG1-kappa
10-947 Balstilimab (PDCD1/PD1/CD279) Homo sapiens / PDCD1/PD1/CD279 [Homo sapiens] IgG4-kappa
21-868 Bamlanivimab Humanized / RBD [SARS-CoV-2] Human IgG
21-887 Bamlanivimab Homo sapiens / SARS-CoV-2 Spike IgG1,Kappa
10-270 Bapineuzumab (APP Abeta) Humanized / APP Abeta [Homo sapiens] IgG1-nd
21-888 Bapotulimab Homo sapiens / ILDR2 IgG2,Kappa
21-889 Barecetamab Homo sapiens / ERBB3 IgG1,Lambda
10-169 Basiliximab (IL2RA/CD25) Chimeric / IL2RA/CD25 [Homo sapiens] IgG1-kappa
11-012 Basilixumab (IL-2 receptor)   IgG1k
10-972 Batoclimab (FCGRT) Homo sapiens / FCGRT [Homo sapiens] IgG1-lambda
10-170 Bavituximab (Phosphatidylserine) Chimeric / Phosphatidylserine [Homo sapiens] IgG1-kappa
10-957 Bedinvetmab (NGF/NGFB) Caninized / NGF/NGFB [Canis lupus familiaris] IgG2-lambda
10-973 Befovacimab (TFPI ) Homo sapiens,Humanized / TFPI [Homo sapiens] IgG2-lambda
10-668 Begelomab (DPP4/TP103/CD26) Mus musculus / DPP4/TP103/CD26 [Homo sapiens] IgG2b-kappa
10-899 Belantamab (TNFRSF17/CD269) Humanized / TNFRSF17/CD269 [Homo sapiens] IgG1-kappa
10-282 Belimumab (TNFSF13B/CD257) Homo sapiens / TNFSF13B/CD257 [Homo sapiens] IgG1-lambda
10-861 Bemarituzumab (FGFR2) Humanized / FGFR2 [Homo sapiens] IgG1-kappa
10-346 Benralizumab (IL5RA/CD12) Humanized / IL5RA/CD12 [Homo sapiens] IgG1-kappa
10-974 Benufutamab (TNFRSF10B/TRAILR2/ CD262) Chimeric,Humanized / TNFRSF10B/TRAILR2/ CD262 [Homo sapiens] IgG1-kappa
10-855 Berlimatoxumab (LukGH) Homo sapiens / LukGH [Staphylococcus aureus] IgG1-kappa
10-694 Bermekimab (IL1A) Humanized / IL1A [Homo sapiens] IgG1-kappa
10-882 Bersanlimab (ICAM1/CD54) Homo sapiens / ICAM1/CD54 [Homo sapiens] IgG1-lambda
10-191 Bertilimumab (CCL11) Homo sapiens / CCL11 [Homo sapiens] IgG4-kappa
10-275 Besilesomab (CEACAM8/CD66b) Mus musculus / CEACAM8/CD66b [Homo sapiens] IgG1-kappa
10-068 Bevacizumab (VEGFA) Humanized / VEGFA [Homo sapiens] IgG1-kappa
10-484 Bezlotoxumab (toxin B) Homo sapiens / toxin B [Clostridium difficile] IgG1-kappa
10-154 Biciromab (Fibrin II beta chain,fibrin) Mus musculus / Fibrin II beta chain,fibrin [Homo sapiens] Fab'-G1-kappa
10-587 Bimagrumab (ACVR2A/ACVR2B) Homo sapiens / ACVR2A/ACVR2B [Homo sapiens] IgG1-lambda
10-652 Bimekizumab (IL17A) Humanized / IL17A [Homo sapiens] IgG1-kappa
10-776 Birtamimab (SAA1) Chimeric,Humanized / SAA1 [Homo sapiens] IgG1-kappa
10-295 Bivatuzumab (CD44 /CD44V) Humanized / CD44 /CD44V [Homo sapiens] IgG1-kappa
10-732 Bleselumab (CD40/ TNFRSF5) Homo sapiens / CD40/ TNFRSF5 [Homo sapiens] IgG4-kappa
10-128 Blinatumomab (CD19/CD3E) Mus musculus / CD19/CD3E [Homo sapiens] (scFv-kappa-heavy)-(scFv-heavy-kappa)
10-462 Blosozumab (SOST(sclerostin)) Humanized / SOST(sclerostin) [Homo sapiens] IgG4-kappa
21-852 BMS-986253, HuMax-IL8, HuMax-Inflam/MDX018 Humanized / IL-8 (Granulocyte chemotactic protein 1, Monocyte-derived neutrophil-activating peptide, IL-8 (1-77), IL-8 (9-77), Monocyte-derived neutrophil chemotactic factor, IL-8 (7-77), (Ser-IL-8)72, GCP/IL-8 protein V, MONAP, C-X-C motif chemokine 8, GCP/IL-8 protein I, Neutrophil-ac ) [Homo sapiens] IgG1
10-651 Bococizumab (PCSK9/NARC1/ PC9) Humanized / PCSK9/NARC1/ PC9 [Homo sapiens] IgG2-kappa
21-890 Botensilimab Homo sapiens / CTLA4 IgG1,Kappa
10-804 Brazikumab (IL23A) Homo sapiens / IL23A [Homo sapiens] IgG2-lambda
21-857 Brentuximab Humanized / TNFRSF8 (CD30, D1S166E, Ki-1) [Homo sapiens] Human IgG1
10-183 Briakinumab (IL12B) Homo sapiens / IL12B [Homo sapiens] IgG1-lambda
10-463 Brodalumab (IL17RA/CD217) Homo sapiens / IL17RA/CD217 [Homo sapiens] IgG2-kappa
10-687 Brolucizumab (VEGFA) Humanized / VEGFA [Homo sapiens] scFv-kappa-heavy
10-657 Brontictuzumab (NOTCH1) Humanized / NOTCH1 [Homo sapiens] IgG2-lambda
10-906 Budigalimab (PDCD1/PD1/CD279) Chimeric,Humanized / PDCD1/PD1/CD279 [Homo sapiens] IgG1-kappa
10-786 Burosumab (FGF23) Homo sapiens / FGF23 [Homo sapiens] IgG1-kappa
11-054 Cabiralizumab (CSF1R/CD115) Humanized / CSF1R/CD115 [Homo sapiens] IgG4-kappa
21-891 Cadonilimab Humanized / PDCD1, CTLA4 Bispecific ,IgG1;Kappa;Lambda
10-250 Camidanlumab (IL2RA/CD25) Homo sapiens / IL2RA/CD25 [Homo sapiens] IgG1-kappa
10-141 Campath-9H (CD4) Mus musculus,Humanized / CD4 [Homo sapiens] IgG1-kappa
10-798 Camrelizumab (PDCD1/PD-1/CD279) Humanized / PDCD1/PD-1/CD279 [Homo sapiens] IgG4-kappa
10-265 Canakinumab (IL1B) Homo sapiens / IL1B [Homo sapiens] IgG1-kappa
10-082 Cantuzumab Mertansine (CA242) Humanized / CA242 [Homo sapiens] IgG1-kappa
10-476 Caplacizumab (VWF  A1 domain) Humanized / VWF A1 domain [Homo sapiens] VH-VH
24-278 carcinoembryonic antigen (CEA) Antibody [Arcitumomab], Human IgG1 Carcinoembryonic antigen (CEA) describes a set of highly related glycoproteins involved in cell adhesion normally produced in gastrointestinal tissue during fetal development, but only at very low levels in adults. IgG1 kappa
24-279 carcinoembryonic antigen (CEA) Antibody [Arcitumomab], Rabbit IgG Carcinoembryonic antigen (CEA) describes a set of highly related glycoproteins involved in cell adhesion normally produced in gastrointestinal tissue during fetal development, but only at very low levels in adults. IgG kappa
10-446 Carlumab (CCL2/MCP-1/MCAF/SCYA2) Homo sapiens / CCL2/MCP-1/MCAF/SCYA2 [Homo sapiens] IgG1-kappa
10-769 Carotuximab (ENG) Chimeric / ENG [Homo sapiens] IgG1-kappa
21-892 Casirivimab Homo sapiens / SARS-CoV-2 Spike RBD IgG1,Kappa
10-171 cBR96 (Lewis Y) Chimeric,Humanized / Lewis Y [Homo sapiens] IgG1-kappa, 
24-490 CCR4 Antibody [KW-0761 (Mogamulizumab)], Rabbit IgG This antibody was prepared by humanization of a mouse anti-CCR4 mAb. IgG kappa
24-427 CD11a Antibody [hu1124 (Efalizumab)], Human IgG1 Efalizumab binds to CD11a, a subunit of leukocyte function antigen-1 (LFA-1), which is expressed on all leukocytes. IgG1 kappa
24-428 CD11a Antibody [hu1124 (Efalizumab)], Rabbit IgG Efalizumab binds to CD11a, a subunit of leukocyte function antigen-1 (LFA-1), which is expressed on all leukocytes. IgG kappa
24-803 CD154 Antibody [IDEC-131 (Toralizumab)], Mouse IgG1 The original monoclonal antibody was generated by immunization with a soluble fusion protein of human gp39 (gp39-CD8). IgG1 kappa
24-804 CD154 Antibody [IDEC-131 (Toralizumab)], Rabbit IgG The original monoclonal antibody was generated by immunization with a soluble fusion protein of human gp39 (gp39-CD8). IgG kappa
24-125 CD20 Antibody [10F381 (rituximab)], Human IgG1 Human lymphoblastoid cell line SB. IgG1 kappa
24-126 CD20 Antibody [10F381 (rituximab)], Rabbit IgG Human lymphoblastoid cell line SB. IgG kappa
24-491 CD22 Antibody [hL22 (Epratuzumab)], Human IgG1 This antibody was prepared by the humanization of LL2 (EPB-2), a murine anti-CD22 IgG2a raised against Raji Burkitt lymphoma cells. Murine sequences comprise 5–10% of the molecule, with the remainder being human framework sequences, which greatly reduces the potential for immunogenicity (Traczewski, 2010). IgG1 kappa
24-492 CD22 Antibody [hL22 (Epratuzumab)], Rabbit IgG This antibody was prepared by the humanization of LL2 (EPB-2), a murine anti-CD22 IgG2a raised against Raji Burkitt lymphoma cells. Murine sequences comprise 5–10% of the molecule, with the remainder being human framework sequences, which greatly reduces the potential for immunogenicity (Traczewski, 2010). IgG kappa
24-282 CD33 Antibody [hP67.6 (Gemtuzumab)], Human IgG4 Gemtuzumab was generated by huminization of the murine  P67.6 clone, raised against CD33-transfected FMY9S5 cells of human origin. CD33 is a transmembrane receptor expressed on predominantly on cells of the myeloid lineage, but it can also be found on some lymphoid cells. IgG4 kappa
24-283 CD33 Antibody [hP67.6 (Gemtuzumab)], Rabbit IgG Gemtuzumab was generated by huminization of the murine  P67.6 clone, raised against CD33-transfected FMY9S5 cells of human origin. CD33 is a transmembrane receptor expressed on predominantly on cells of the myeloid lineage, but it can also be found on some lymphoid cells. IgG kappa
24-392 CD4 Antibody [CE9.1 (Clenoliximab)], Human IgG4 Domain 1 of human CD4. IgG4 lambda
24-393 CD4 Antibody [CE9.1 (Clenoliximab)], Rabbit IgG Domain 1 of human CD4. IgG lambda
24-386 CD40L Antibody [hu5c8 (Ruplizumab)], Human IgG1 Human CD40L IgG1 kappa
24-387 CD40L Antibody [hu5c8 (Ruplizumab)], Rabbit IgG Human CD40L IgG kappa
24-280 CD41 Antibody [7E3 (Abciximab)], Human IgG1 CD41 is the integrin alpha chain 2b forming a fibrinogen receptor in heterodimeric complex with beta 3. IgG1 kappa
24-281 CD41 Antibody [7E3 (Abciximab)], Rabbit IgG CD41 is the integrin alpha chain 2b forming a fibrinogen receptor in heterodimeric complex with beta 3. IgG kappa
24-499 CD80 Antibody [IDEC-114 (Galiximab)], Human IgG1 Galiximab was prepared by immunizing cynomolgus monkeys with recombinant CD80 antigen. The variable regions of the light and heavy chains were then cloned by being incorporated into a cassette vector (N5LG1) containing human constant region genes and subsequently transfected into the Dg44 CHO cell line (Hariharan K, 2013) IgG1 lambda
24-500 CD80 Antibody [IDEC-114 (Galiximab)], Rabbit IgG Galiximab was prepared by immunizing cynomolgus monkeys with recombinant CD80 antigen. The variable regions of the light and heavy chains were then cloned by being incorporated into a cassette vector (N5LG1) containing human constant region genes and subsequently transfected into the Dg44 CHO cell line (Hariharan K, 2013) IgG lambda
10-240 CDP571 (TNFSF2/TNF alpha/TNFA)   IgG4-kappa
10-907 Cemiplimab (PDCD1/PD1/CD279) Homo sapiens / PDCD1/PD1/CD279 [Homo sapiens] IgG4-kappa
10-946 Cendakimab (IL13) Humanized / IL13 [Homo sapiens] IgG1-kappa
21-855 Certolizumab   Fab-IgG1
10-891 Cetrelimab (PDCD1/PD1/CD279) Homo sapiens / PDCD1/PD1/CD279 [Homo sapiens] IgG4-kappa
10-172 Cetuximab (EGFR) Chimeric / EGFR [Homo sapiens] IgG1-kappa
10-880 Cibisatamab (CD3E/CEACAM5) Humanized / CD3E/CEACAM5 [Homo sapiens] IgG1-kappa/lambda with domain crossover
21-870 Cilgavimab Humanized / RBD [SARS-CoV-2] Human IgG
21-893 Cilgavimab Homo sapiens / SARS-CoV-2 Spike RBD IgG1,Kappa
10-962 Cinpanemab (SNCA ) Humanized / SNCA [Homo sapiens] IgG1-lambda
10-258 Citatuzumab Bogatox (EPCAM/CD326) Humanized / EPCAM/CD326 [Homo sapiens] Fab-G1-kappa
10-299 Cixutumumab (IGF1R/CD221) Homo sapiens / IGF1R/CD221 [Homo sapiens] IgG1-lambda
10-486 Clazakizumab (IL6) Humanized / IL6 [Homo sapiens] IgG1-kappa
10-173 Clenoliximab (CD4) Chimeric / CD4 [Homo sapiens] IgG4-lambda
21-894 Clervonafusp Humanized / SLC29A2 IgG1,Kappa
10-729 Clivatuzumab Tetraxetan (MUC1/CD227) Humanized / MUC1/CD227 [Homo sapiens] IgG1-kappa
10-239 CMB-401 (MUC1/CD227) Homo sapiens / MUC1/CD227 [Homo sapiens] IgG1-nd
10-929 Cobolimab (HAVCR2/TIM3/CD366) Humanized / HAVCR2/TIM3/CD366 [Homo sapiens] IgG4-kappa
10-597 Codrituzumab (GPC3) Humanized / GPC3 [Homo sapiens] IgG1-kappa
10-859 Cofetuzumab (PTK7) Humanized / PTK7 [Homo sapiens] IgG1-kappa
10-655 Coltuximab Ravtansine (CD19 ) Chimeric / CD19 [Homo sapiens] IgG1-kappa
10-245 Conatumumab (TNFRSF10B/CD262) Homo sapiens / TNFRSF10B/CD262 [Homo sapiens] IgG1-kappa
10-578 Concizumab (TFPI) Humanized / TFPI [Homo sapiens] IgG4-kappa
21-895 Coprelotamab Humanized / ERBB2 IgG1,Kappa
10-835 Cosfroviximab (Zaire Ebola virus ) Chimeric / Zaire Ebola virus [Zaire ebolavirus] IgG1-kappa
10-975 Cosibelimab (CD274/PD-L1/B7-H1) Homo sapiens / CD274/PD-L1/B7-H1 [Homo sapiens] IgG1-lambda
10-464 Crenezumab (APP Abeta42 and Abeta40) Humanized / APP Abeta42 and Abeta40 [Homo sapiens] IgG4-kappa
10-808 Crizanlizumab (SELP) Humanized / SELP [Homo sapiens] IgG2-kappa
10-760 Crotedumab (GCGR) Homo sapiens / GCGR [Homo sapiens] IgG4-kappa
10-871 Crovalimab (C5) Chimeric,Humanized / C5 [Homo sapiens] IgG1-kappa
10-166 cT84.66 (CEACAM5/CD66e) Chimeric / CEACAM5/CD66e [Homo sapiens]  
21-896 Cudarolimab Homo sapiens / TNFRSF4 IgG1,Kappa
10-877 Cusatuzumab (CD70/TNFSF7) Humanized / CD70/TNFSF7 [Homo sapiens] IgG1-lambda
10-254 Dacetuzumab (CD40) Humanized / CD40 [Homo sapiens] IgG1-kappa
10-069 Daclizumab (IL2RA) Humanized / IL2RA [Homo sapiens] IgG1-kappa
21-897 Dafsolimab Mus musculus / CD3E IgG2b,Kappa
10-345 Dalotuzumab (IGF1R/CD221) Humanized / IGF1R/CD221 [Homo sapiens] IgG1-kappa
10-631 Dapirolizumab (CD40LG/CD154) Humanized / CD40LG/CD154 [Homo sapiens] Fab'-G1-kappa
10-316 Daratumumab (CD38) Homo sapiens / CD38 [Homo sapiens] IgG1-kappa
21-898 Datopotamab Humanized / TACSTD2 IgG1,Kappa
21-899 Daxdilimab Homo sapiens / LILRA4 IgG1,Lambda
10-688 Dectrekumab (IL13) Homo sapiens / IL13 [Homo sapiens] IgG1-kappa
10-487 Demcizumab (DLL4 ) Humanized / DLL4 [Homo sapiens] IgG2-kappa
21-900 Demupitamab Homo sapiens / EGFR IgG1,Kappa
10-658 Denintuzumab Mafodotin (CD19) Humanized / CD19 [Homo sapiens] IgG1-kappa
10-267 Denosumab (TNFSF11/CD254) Homo sapiens / TNFSF11/CD254 [Homo sapiens] IgG2-kappa
10-783 Depatuxizumab (EGFR) Chimeric,Humanized / EGFR [Homo sapiens] IgG1-kappa
21-901 Depemokimab Humanized / IL5 IgG1,Kappa
10-791 Dezamizumab (APCS) Humanized / APCS [Homo sapiens] IgG1-kappa
10-908 Dilpacimab (DLL4/VEGFA) Humanized / DLL4/VEGFA [Homo sapiens] IgG1-kappa
10-595 Dinutuximab (ganglioside GD2) Chimeric / ganglioside GD2 [Homo sapiens] IgG1-kappa
10-659 Diridavumab (influenza A virus hemagglutinin HA2 subunit from various strains) Homo sapiens / influenza A virus hemagglutinin HA2 subunit from various strains [Influenza A virus] IgG1-lambda
10-963 Disitamab (ERBB2/EGFR2/CD340) Humanized / ERBB2/EGFR2/CD340 [Homo sapiens] IgG1-kappa
21-902 Divozilimab Humanized / MS4A1 IgG1,Kappa
21-903 Docaravimab Mus musculus / Rabies Virus Strain ERA GP Ectodomain Epitope G-III IgG2b,Kappa
10-774 Domagrozumab (MSTN /GDF8) Humanized / MSTN /GDF8 [Homo sapiens] IgG1-kappa
21-904 Domvanalimab Humanized / TIGIT IgG1,Kappa
10-934 Donanemab (APP) Humanized / APP [Homo sapiens] IgG1-kappa
10-909 Dostarlimab (PDCD1/PD1/CD279) Humanized / PDCD1/PD1/CD279 [Homo sapiens] IgG4-kappa
10-349 Drozitumab (TNFRSF10B/TRAILR2/CD262) Homo sapiens / TNFRSF10B/TRAILR2/CD262 [Homo sapiens] IgG1-lambda
10-488 Duligotuzumab (ERBB3 ) Humanized / ERBB3 [Homo sapiens] IgG1-kappa
10-580 Dupilumab (IL4R/CD124) Homo sapiens / IL4R/CD124 [Homo sapiens] IgG4-kappa
10-680 Durvalumab (CD274/B7-H1/PDL1) Homo sapiens / CD274/B7-H1/PDL1 [Homo sapiens] IgG1-kappa
10-582 Dusigitumab (IGF1/IGF2) Homo sapiens / IGF1/IGF2 [Homo sapiens] IgG2-nd
10-780 Duvortuxizumab (CD19/CD3E) Chimeric,Humanized / CD19/CD3E [Homo sapiens] scFv -h-CH2-CH3(_scFv)_h-CH2-CH3
21-905 Ebdarokimab Humanized / IL12B IgG1,Kappa
21-906 Ebronucimab Homo sapiens / PCSK9 IgG1,Lambda
10-288 Ecromeximab (ganglioside GD4) Chimeric / ganglioside GD4 [Homo sapiens] IgG1-kappa
10-070 Eculizumab (C5) Humanized / C5 [Homo sapiens] IgG2-G4-kappa
10-142 Edobacomab (Endotoxin) Mus musculus / Endotoxin [Gram negative bacteria] IgM-nd
10-143 Edrecolomab (EPCAM) Mus musculus / EPCAM [Homo sapiens] IgG2a-kappa
10-194 Efungumab (HSP91 homolog) Homo sapiens / HSP91 homolog [Candida albicans] scFv-heavy-kappa
24-274 EGFR Antibody [C225 (Cetuximab)], Human IgG1 The epidermal growth factor receptor  is the cell-surface receptor for members of the epidermal growth factor family (EGF-family) of extracellular protein ligands. IgG1 kappa
24-275 EGFR Antibody [C225 (Cetuximab)], Rabbit IgG The epidermal growth factor receptor  is the cell-surface receptor for members of the epidermal growth factor family (EGF-family) of extracellular protein ligands. IgG kappa
24-425 EGFR Antibody [Matuzumab], Human IgG1 The parental mouse antibody was generated by immunizing BALB/c mice intraperitoneally with A431 cells in phosphate buffered saline (PBS).  Later on the humanzied version of the antibody was created by grafting CDRs of the murine antibody onto human constant  regions. IgG1 kappa
24-426 EGFR Antibody [Matuzumab], Rabbit IgG The parental mouse antibody was generated by immunizing BALB/c mice intraperitoneally with A431 cells in phosphate buffered saline (PBS).  Later on the humanzied version of the antibody was created by grafting CDRs of the murine antibody onto human constant  regions. IgG kappa
24-488 EGFR domain III Antibody [h-R3 (Nimotuzumab)], Human IgG1 This antibody we generated by humanisation of the murine antibody R3, raised against EGFR purified from placenta membranes and A431 tumors. IgG1 kappa
24-489 EGFR domain III Antibody [h-R3 (Nimotuzumab)], Rabbit IgG This antibody we generated by humanisation of the murine antibody R3, raised against EGFR purified from placenta membranes and A431 tumors. IgG kappa
10-594 Eldelumab (CXCL10) Homo sapiens / CXCL10 [Homo sapiens] IgG1-kappa
10-789 Elezanumab (RGMA) Homo sapiens / RGMA [Homo sapiens] IgG1-lambda
10-685 Elgemtumab (ERBB3) Homo sapiens / ERBB3 [Homo sapiens] IgG1-kappa
10-944 Elipovimab (HIV-1 gp120) Homo sapiens / HIV-1 gp120 [Human immunodeficiency virus 1] IgG1-lambda
10-307 Elotuzumab (SLAMF7/CD319) Humanized / SLAMF7/CD319 [Homo sapiens] IgG1-kappa
10-283 Elsilimomab (IL6) Mus musculus / IL6 [Homo sapiens] IgG1-nd
21-907 Eluvixtamab Humanized / CD33, CD3E Bispecific scFvKappa;Lambda
10-666 Emactuzumab (CSF1R/CD115) Humanized / CSF1R/CD115 [Homo sapiens] IgG1-kappa
10-806 Emapalumab (IFNG ) Homo sapiens / IFNG [Homo sapiens] IgG1-lambda
21-908 Emerfetamab Humanized / CD33, CD3E Bispecific scFv;Kappa;Lambda
10-661 Emibetuzumab (MET/RCCP2) Humanized / MET/RCCP2 [Homo sapiens] IgG4-kappa
10-733 Emicizumab (F10/F9  activated form) Humanized / F10/F9 activated form [Homo sapiens] IgG4-kappa
10-895 Enapotamab (AXL) Homo sapiens / AXL [Homo sapiens] IgG1-kappa
10-447 Enavatuzumab (TNFRSF12A/CD266) Humanized / TNFRSF12A/CD266 [Homo sapiens] IgG1-kappa
10-977 Encelimab (LAG3/CD223) Humanized / LAG3/CD223 [Homo sapiens] IgG4-kappa
10-625 Enfortumab Vedotin (PVRL4) Homo sapiens / PVRL4 [Homo sapiens] IgG1-kappa
21-909 Enibarcimab Humanized / ADM IgG1,Kappa
10-144 Enlimomab (ICAM1) Mus musculus / ICAM1 [Homo sapiens] IgG2a-nd
10-755 Enoblituzumab (CD276/B7-H3) Humanized / CD276/B7-H3 [Homo sapiens] IgG1-kappa
10-448 Enokizumab (IL9) Humanized / IL9 [Homo sapiens] IgG1-kappa
10-489 Enoticumab (DLL4 ) Homo sapiens / DLL4 [Homo sapiens] IgG1-kappa
10-354 Ensituximab (MUC5AC) Chimeric / MUC5AC [Homo sapiens] IgG1-kappa
10-964 Envafolimab (CD274/PD-L1/B7-H1) Chimeric / CD274/PD-L1/B7-H1 [Homo sapiens] (VH-CH2-CH3)2
10-978 Epcoritamab (CD3E;MS4A1/CD20) Homo sapiens,Chimeric / CD3E;MS4A1/CD20 [Homo sapiens] IgG4-kappa-lambda
10-318 Epitumomab (MUC1/CD227) Mus musculus / MUC1/CD227 [Homo sapiens] IgG2a-nd
10-073 Epratuzumab (CD22) Humanized / CD22 [Homo sapiens] IgG1-nd
10-787 Eptinezumab (CALCA /CALCB) Humanized / CALCA /CALCB [Homo sapiens] IgG1-kappa
24-087 erbB-2 (Her-2/neu) Antibody [4D5-8 (trastuzumab)], Human IgG1 A431 cells (human epidermoid carcinoma) (over)expressing EGFR. IgG1 kappa
24-088 erbB-2 (Her-2/neu) Antibody [4D5-8 (trastuzumab)], Rabbit IgG A431 cells (human epidermoid carcinoma) (over)expressing EGFR. IgG kappa
10-775 Erenumab (CALCRL/CGRP-R) Homo sapiens / CALCRL/CGRP-R [Homo sapiens] IgG2-lambda
21-910 Erfonrilimab Humanized / CD274, CTLA4 Bispecific Single Domains (VH-VH'-CH),IgG1na;na
10-292 Erlizumab (ITGB2/CD18 ) Humanized / ITGB2/CD18 [Homo sapiens] IgG1-nd
10-243 Ertumaxomab (CD3E/ERBB2/CD340) Mus musculus,Rattus sp,Hybrid / CD3E/ERBB2/CD340 [Homo sapiens] IgG2a-kappa/G2b-lambda
10-261 Etaracizumab (ITGAV_ITGB3) Humanized / ITGAV_ITGB3 [Homo sapiens] IgG1-nd
21-880 Etesevimab Humanized / GP1 surface protein of Ebolavirus Human IgG1
21-911 Etesevimab Homo sapiens / SARS-CoV-2 Spike RBD IgG1,Kappa
10-885 Etigilimab (TIGIT/VSTM3) Humanized / TIGIT/VSTM3 [Homo sapiens] IgG1-kappa
10-931 Etokimab (IL33) Humanized / IL33 [Homo sapiens] IgG1-kappa
10-449 Etrolizumab (ITGA4_ITGB7) Humanized / ITGA4_ITGB7 [Homo sapiens] IgG1-kappa
10-681 Evinacumab (ANGPTL3) Homo sapiens / ANGPTL3 [Homo sapiens] IgG4-kappa
10-579 Evolocumab (PCSK9) Homo sapiens / PCSK9 [Homo sapiens] IgG2-lambda
10-279 Exbivirumab (HBV/HBsAg) Homo sapiens / HBV/HBsAg [Hepatitis B virus] IgG1-lambda
21-912 Ezabenlimab Humanized / PDCD1 IgG4,Kappa
10-320 Faralimomab (IFNA1) Mus musculus / IFNA1 [Homo sapiens] IgG1-nd
10-878 Faricimab (ANGPT2/VEGFA) Homo sapiens,Humanized / ANGPT2/VEGFA [Homo sapiens] IgG1-kappa-lambda
10-308 Farletuzumab (FOLR1 ) Humanized / FOLR1 [Homo sapiens] IgG1-kappa
10-490 Fasinumab (NGF/NGFB ) Homo sapiens / NGF/NGFB [Homo sapiens] IgG4-kappa
21-913 Feladilimab Humanized / ICOS IgG4,Kappa
10-099 Felvizumab (RSV) Humanized / RSV [Respiratory syncytial virus] IgG1-kappa
10-336 Fezakinumab (IL22) Homo sapiens / IL22 [Homo sapiens] IgG1-lambda
10-979 Fianlimab (LAG3/CD223) Homo sapiens / LAG3/CD223 [Homo sapiens] IgG4-kappa
10-465 Ficlatuzumab (HGF) Humanized / HGF [Homo sapiens] IgG1-kappa
10-309 Figitumumab (IGF1R/CD221) Homo sapiens / IGF1R/CD221 [Homo sapiens] IgG2-kappa
21-914 Finotonlimab Humanized / PDCD1 IgG4,Kappa
10-671 Firivumab (Influenza A virus hemagglutinin HA) Homo sapiens / Influenza A virus hemagglutinin HA [Influenza A virus] IgG1-kappa
10-478 Flanvotumab (TYRP1) Homo sapiens / TYRP1 [Homo sapiens] IgG1-kappa
10-630 Fletikumab (IL20 ) Homo sapiens / IL20 [Homo sapiens] IgG4-kappa
10-818 Flotetuzumab (CD3E/IL3RA/CD123) Mus musculus;Humanized / CD3E/IL3RA/CD123 [Homo sapiens] VH-VL-VH'-VL'
10-074 Fontolizumab (IFNG) Humanized / IFNG [Homo sapiens] IgG1-nd
10-437 Foralumab (CD3E) Homo sapiens / CD3E [Homo sapiens] IgG1-kappa
10-125 Foravirumab (RV) Homo sapiens / RV [Rabies virus] IgG1-kappa
10-785 Fremanezumab (CALCA /CALCB) Humanized / CALCA /CALCB [Homo sapiens] IgG2-kappa
10-195 Fresolimumab (TGFB/TGF beta) Homo sapiens / TGFB/TGF beta [Homo sapiens] IgG4-kappa
10-910 Frovocimab (PCSK9) Humanized / PCSK9 [Homo sapiens] IgG4-kappa
10-824 Frunevetmab (NGF/NGFB) Felinized / NGF/NGFB [Mus musculus] IgG1-kappa
10-450 Fulranumab (NGF/NGFB) Homo sapiens / NGF/NGFB [Homo sapiens] IgG2-kappa
10-491 Futuximab (EGFR  domain III /ERBB1) Chimeric / EGFR domain III /ERBB1 [Homo sapiens] IgG1-kappa
10-773 Galcanezumab (CALCA/CGRP1/CALCB/CGRP2) Humanized / CALCA/CGRP1/CALCB/CGRP2 [Homo sapiens] IgG4-kappa
10-175 Galiximab (CD80 (B7-1,CD28LG2)) Chimeric / CD80 (B7-1,CD28LG2) [Homo sapiens] IgG1-lambda
10-925 Gancotamab (ERBB2/EGFR2/CD340) Homo sapiens / ERBB2/EGFR2/CD340 [Homo sapiens] scFv-heavy-lambda
10-189 Ganitumab (IGF1R/CD221) Homo sapiens / IGF1R/CD221 [Homo sapiens] IgG1-kappa
10-244 Gantenerumab (APP /Abeta42/Abeta40) Homo sapiens / APP /Abeta42/Abeta40 [Homo sapiens] IgG1-kappa
10-949 Garadacimab (F12) Humanized / F12 [Homo sapiens] IgG4-lambda
10-817 Garetosmab (INHBA) Humanized / INHBA [Homo sapiens] IgG4-kappa
21-915 Garivulimab Humanized / CD274 IgG1,Kappa
10-842 Gatipotuzumab (MUC1/CD227) Humanized / MUC1/CD227 [Homo sapiens] IgG1-kappa
10-980 Gatralimab (CD52) Chimeric,Humanized / CD52 [Homo sapiens] IgG1-kappa
10-828 Gedivumab (Influenza A virus hemagglutinin HA) Homo sapiens / Influenza A virus hemagglutinin HA [Influenza A virus] IgG1-kappa
10-081 Gemtuzumab (CD33) Humanized / CD33 [Homo sapiens] IgG4-kappa
21-916 Geptanolimab Humanized / PDCD1 IgG4,Kappa
10-129 Gevokizumab (IL1B) Humanized / IL1B [Homo sapiens] IgG2-kappa
10-834 Gilvetmab (PDCD1/PD1/CD279) Caninized / PDCD1/PD1/CD279 [Canis lupus familiaris] IgG2-kappa
10-847 Gimsilumab (CSF2 /GM-CSF) Homo sapiens / CSF2 /GM-CSF [Homo sapiens] IgG1-kappa
10-341 Girentuximab (CA9) Chimeric / CA9 [Homo sapiens] IgG1-kappa
10-344 Glembatumumab (GPNMB extracellular domain) Homo sapiens / GPNMB extracellular domain [Homo sapiens] IgG2-kappa
10-938 Glenzocimab (GP6) Humanized / GP6 [Homo sapiens] Fab-G1-kappa
10-981 Glofitamab (CD3E/MS4A1) Humanized / CD3E/MS4A1 [Homo sapiens] IgG1-kappa-lambda
10-196 Golimumab (TNFA/TNF alpha) Homo sapiens / TNFA/TNF alpha [Homo sapiens] IgG1-kappa
21-917 Gomiliximab   IgG1,Kappa
10-911 Gosuranemab (MAPT) Chimeric / MAPT [Homo sapiens] IgG4-kappa
10-982 Gremubamab (PcrV) Homo sapiens,Humanized / PcrV [Bradyrhizobium sp.ANU 289,Gram negative bacteria] VH-CH1-VH-V-KAPPA-CH2-CH3
21-918 Grisnilimab Mus musculus / CD7 IgG2a,Lambda
10-599 Guselkumab (IL23A) Homo sapiens / IL23A [Homo sapiens] IgG1-lambda
10-136 Huj591-Gsmab (FOLH1/PSMA) Mus musculus / FOLH1/PSMA [Homo sapiens]  
24-375 Human Muscle Acetylcholine Receptor Antibody [mAb 192], Rat IgG2b Human muscle AChR. IgG2b kappa
10-198 Humax-Il15 (IL15) Homo sapiens / IL15 [Homo sapiens] IgG1-kappa
10-849 Ianalumab (TNFRSF13C/CD268) Homo sapiens / TNFRSF13C/CD268 [Homo sapiens] IgG1-kappa
10-262 Ibalizumab (CD4 D3 domain) Humanized / CD4 D3 domain [Homo sapiens] IgG4-kappa
21-856 Ibritumomab Humanized / MS4A1 (CD20, MS4A-1) [Homo sapiens] Human IgG2A
10-176 ICM3 (CD50) Chimeric,Humanized / CD50 [Homo sapiens]  
10-451 Icrucumab (FLT1/ VEGFR-1) Homo sapiens / FLT1/ VEGFR-1 [Homo sapiens] IgG1-kappa
21-919 Idactamab Homo sapiens / SLC1A5 IgG1,Kappa
10-593 Idarucizumab (dabigatran etexilate mesylate) Humanized / dabigatran etexilate mesylate [Drug] Fab-G1-kappa
10-951 Ieramilimab (LAG3 ) Humanized / LAG3 [Homo sapiens] IgG4-kappa
10-740 Ifabotuzumab (EPHA3/REK4) Humanized / EPHA3/REK4 [Homo sapiens] IgG1-kappa
24-241 IL-2R alpha (CD25) Antibody [Basiliximab], Human IgG1 Basiliximab was prepared by immunizing BALB/c mice with CTC 16 cells. IgG1 kappa
24-242 IL-2R alpha (CD25) Antibody [Basiliximab], Rabbit IgG Basiliximab was prepared by immunizing BALB/c mice with CTC 16 cells. IgG kappa
24-239 IL-2R Antibody [Daclizumab], Human IgG1 Cultured T-cells derived from a patient with Mycosis fungoides. IgG1 kappa
24-240 IL-2R Antibody [Daclizumab], Rabbit IgG Cultured T-cells derived from a patient with Mycosis fungoides. IgG kappa
24-501 IL-6 receptor Antibody [rhPM-1 (Tocilizumab)], Human IgG1 The original antibody was generated by CDR grafting of mouse PM-1 antibody onto human REI and NEW framework regions to create rhPM-1. IgG1 kappa
24-502 IL-6 receptor Antibody [rhPM-1 (Tocilizumab)], Rabbit IgG The original antibody was generated by CDR grafting of mouse PM-1 antibody onto human REI and NEW framework regions to create rhPM-1. IgG kappa
10-857 Iladatuzumab (CD79B) Humanized / CD79B [Homo sapiens] IgG1-kappa
10-669 Imalumab (MIF) Homo sapiens / MIF [Homo sapiens] IgG1-kappa
10-890 Imaprelimab (MCAM) Humanized / MCAM [Homo sapiens] IgG1-kappa
10-199 IMC-1C11 (VEGFA) Chimeric / VEGFA [Homo sapiens]  
21-920 Imdevimab Homo sapiens / SARS-CoV-2 Spike RBD IgG1,Lambda
10-492 Imgatuzumab (EGFR ) Humanized / EGFR [Homo sapiens] IgG1-kappa
21-921 Imsidolimab Humanized / IL36R IgG4,Kappa
10-477 Inclacumab (SELP) Homo sapiens / SELP [Homo sapiens] IgG4-kappa
10-474 Indatuximab Ravtansine (SDC1/CD138) Chimeric / SDC1/CD138 [Homo sapiens] IgG4-kappa
10-693 Indusatumab (GUCY2C) Homo sapiens / GUCY2C [Homo sapiens] IgG1-kappa
10-700 Inebilizumab (CD19) Humanized / CD19 [Homo sapiens] IgG1-kappa
10-177 Infliximab (TNF-alpha) Chimeric / TNF-alpha [Homo sapiens] IgG1-kappa
10-150 Inolimomab (IL2RA) Mus musculus / IL2RA [Homo sapiens] IgG1-kappa
10-276 Inotuzumab Ozogamicin (CD22) Humanized / CD22 [Homo sapiens] IgG4-kappa
24-484 Integrin alpha 4 Antibody [Natalizumab], Human IgG4 The RAMOS cell line, a non-EBV releasing cell line, injected into mice. IgG4 kappa
24-485 Integrin alpha 4 Antibody [Natalizumab], Rabbit IgG The RAMOS cell line, a non-EBV releasing cell line, injected into mice. IgG kappa
10-334 Intetumumab (ITGAV_ITGB3) Homo sapiens / ITGAV_ITGB3 [Homo sapiens] IgG1-kappa
10-779 Iodine (131I) Apamistamab (PTPRC/CD45) Mus musculus / PTPRC/CD45 [Homo sapiens] IgG1-kappa
10-165 Iodine (131I) Derlotuximab Biotin (DNA/histone(H1) complex) Chimeric / DNA/histone(H1) complex [Homo sapiens] IgG1-kappa
10-214 Ipilimumab (CTLA4/CD152) Homo sapiens / CTLA4/CD152 [Homo sapiens] IgG1-kappa
10-268 Iratumumab (TNFRSF8/CD30) Homo sapiens / TNFRSF8/CD30 [Homo sapiens] IgG1-kappa
10-690 Isatuximab (CD38) Chimeric / CD38 [Homo sapiens] IgG1-kappa
10-881 Iscalimab (CD40/TNFRSF5) Homo sapiens / CD40/TNFRSF5 [Homo sapiens] IgG1-kappa
10-695 Istiratumab (ERBB3/IGF1R/CD221) Homo sapiens / ERBB3/IGF1R/CD221 [Homo sapiens] IgG1-kappa -[scFv]2
10-438 Itolizumab (CD6) Humanized / CD6 [Homo sapiens] IgG1-kappa
10-983 Ivuxolimab (TNFRSF4/CD134) Homo sapiens / TNFRSF4/CD134 [Homo sapiens] IgG2-kappa
10-466 Ixekizumab (IL17A ) Humanized / IL17A [Homo sapiens] IgG4-kappa
21-922 Izuralimab Humanized / ICOS, PDCD1 Bispecific Mixed mAb and scFv IgG1;na,Kappa;Kappa
10-215 J695 (IL12A/CD18) Homo sapiens,Humanized / IL12A/CD18 [Homo sapiens] IgG-nd
10-178 Keliximab (CD4) Chimeric / CD4 [Homo sapiens] IgG1-lambda
10-085 Labetuzumab (CEACAM5) Humanized / CEACAM5 [Homo sapiens] IgG-nd
10-833 Lacnotuzumab (CSF1/MCSF) Humanized / CSF1/MCSF [Homo sapiens] IgG1-kappa
10-675 Lacutamab (KIR3DL2) Chimeric,Humanized / KIR3DL2 [Homo sapiens] IgG1-kappa
10-853 Ladiratuzumab (SLC39A6) Humanized / SLC39A6 [Homo sapiens] IgG1-kappa
10-493 Lampalizumab (CFD) Humanized / CFD [Homo sapiens] Fab-G1-kappa
10-771 Lanadelumab (KLKB1) Homo sapiens / KLKB1 [Homo sapiens] IgG1-kappa
10-746 Landogrozumab (MSTN/GDF8) Humanized / MSTN/GDF8 [Homo sapiens] IgG4-kappa
10-765 Laprituximab (EGFR) Chimeric / EGFR [Homo sapiens] IgG1-kappa
10-837 Larcaviximab (Zaire Ebola virus) Chimeric / Zaire Ebola virus [Zaire ebolavirus] IgG1-kappa
21-923 Latozinemab Homo sapiens / SORT1 IgG1,Kappa
10-338 Lebrikizumab (IL13) Humanized / IL13 [Homo sapiens] IgG4-kappa
10-293 Lemalesomab (NCA-90 ) Mus musculus / NCA-90 [Homo sapiens] IgG1-nd
21-924 Lemzoparlimab Humanized / CD47 IgG4,Kappa
10-887 Lenvervimab (HBV) Humanized / HBV [Homo sapiens] IgG1-kappa
10-670 Lenzilumab (CSF2) Homo sapiens / CSF2 [Homo sapiens] IgG1-kappa
10-216 Lerdelimumab (TGFB2) Homo sapiens / TGFB2 [Homo sapiens] IgG4-nd
10-889 Leronlimab (CCR5/CD195) Humanized / CCR5/CD195 [Homo sapiens] IgG4-kappa
10-825 Lesofavumab (Influenza B virus hemagglutinin) Homo sapiens / Influenza B virus hemagglutinin [Influenza B virus] IgG1-kappa
21-925 Letaplimab Homo sapiens / CD47 IgG4,Kappa
10-822 Letolizumab (CD40LG/CD154) Humanized / CD40LG/CD154 [Homo sapiens] (VH-CH2-CH3)2
10-930 Levilimab (IL6R) Chimeric,Humanized / IL6R [Homo sapiens] IgG1-kappa
10-217 Lexatumumab (TNFRSF10B/CD262) Homo sapiens / TNFRSF10B/CD262 [Homo sapiens] IgG1-lambda
10-280 Libivirumab (HBV/HBsAg) Homo sapiens / HBV/HBsAg [Hepatitis B virus] IgG1-kappa
21-926 Licaminlimab Humanized / TNFA Lambda
10-628 Lifastuzumab Vedotin (SLC34A2) Humanized / SLC34A2 [Homo sapiens] IgG1-kappa
10-494 Ligelizumab (IGHE) Humanized / IGHE [Homo sapiens] IgG1-kappa
10-691 Lilotomab (CD37) Mus musculus / CD37 [Homo sapiens] IgG1-kappa
10-083 Lintuzumab (CD33) Humanized / CD33 [Homo sapiens] IgG1-kappa
10-495 Lirilumab (KIRD2 subgroup) Homo sapiens / KIRD2 subgroup [Homo sapiens] IgG4-kappa
10-984 Lodapolimab (PDCD1/PD-1/CD279) Homo sapiens / PDCD1/PD-1/CD279 [Homo sapiens] IgG1-lambda
10-592 Lodelcizumab (PCSK9) Humanized / PCSK9 [Homo sapiens] IgG1-kappa
10-679 Lokivetmab (IL31) Caninized / IL31 [Canis lupus familiaris] IgG2-kappa
10-850 Loncastuximab (CD19 ) Chimeric / CD19 [Homo sapiens] IgG1-kappa
21-927 Lonigutamab Humanized / IGF1R IgG1,Kappa
21-928 Lorukafusp Chimeric / Ganglioside GD2 IgG1,Kappa
10-084 Lorvotuzumab Mertansine (NCAM1/CD56) Humanized / NCAM1/CD56 [Homo sapiens] IgG1-kappa
10-820 Losatuxizumab (EGFR) Chimeric,Humanized / EGFR [Homo sapiens] IgG1-kappa
10-197 Lucatumumab (CD40) Homo sapiens / CD40 [Homo sapiens] IgG1-kappa
10-664 Lulizumab (CD28 ) Humanized / CD28 [Homo sapiens] V-kappa
10-179 Lumiliximab (FCER2) Chimeric / FCER2 [Homo sapiens] IgG1-kappa
10-667 Lumretuzumab (ERBB3) Humanized / ERBB3 [Homo sapiens] IgG1-kappa
10-782 Lupartumab (LYPD3) Homo sapiens / LYPD3 [Homo sapiens] IgG1-lambda
21-929 Lusvertikimab Humanized / IL7R IgG4,Kappa
10-790 Lutikizumab (IL1A /IL1B) Humanized / IL1A /IL1B [Homo sapiens] [VH-VH'-H-Gamma1-VL-VL'-C-kappa]-dimer
10-816 Maftivimab (Zaire Ebola virus) Homo sapiens / Zaire Ebola virus [Zaire ebolavirus] IgG1-kappa
10-950 Magrolimab (CD47 ) Chimeric,Humanized / CD47 [Homo sapiens] IgG4-kappa
10-985 Manelimab (CD274/PD-L1/B7-H1) Homo sapiens / CD274/PD-L1/B7-H1 [Homo sapiens] IgG1-lambda
10-218 Mapatumumab (TNFRSF10A/CD261) Homo sapiens / TNFRSF10A/CD261 [Homo sapiens] IgG1-nd
10-616 Margetuximab (ERBB2/EGFR2/CD340) Chimeric / ERBB2/EGFR2/CD340 [Homo sapiens] IgG1-kappa
10-912 Marstacimab (TFPI) Homo sapiens / TFPI [Homo sapiens] IgG1-lambda
10-332 Maslimomab (T cell receptor) Mus musculus / T cell receptor [Homo sapiens] IgG2b-nd
10-072 Matuzumab (EGFR) Humanized / EGFR [Homo sapiens] IgG1-nd
10-986 Mavezelimab (LAG3/CD223) Humanized / LAG3/CD223 [Homo sapiens] IgG4-kappa
10-347 Mavrilimumab (CSF2RA/CD116 ) Homo sapiens / CSF2RA/CD116 [Homo sapiens] IgG4-lambda2
21-930 Melrilimab Homo sapiens / IL1RL1 IgG2,Kappa
21-853 Meplazumab Humanized / CD147 [Homo sapiens] IgG1-kappa
10-123 Mepolizumab (IL5) Humanized / IL5 [Homo sapiens] IgG1-kappa
10-221 Metelimumab (TGFB1) Homo sapiens / TGFB1 [Homo sapiens] IgG4-kappa
10-928 Mezagitamab (CD38 ) Humanized / CD38 [Homo sapiens] IgG1-lambda
21-931 Mibavademab Humanized / LEPR IgG4,Kappa
10-158 Milatuzumab (CD74) Humanized / CD74 [Homo sapiens] IgG1-kappa
10-324 Minretumomab (TAG-72) Mus musculus / TAG-72 [Homo sapiens] IgG1-nd
21-932 Mipasetamab Humanized / AXL IgG1,Kappa
21-933 Miptenalimab Humanized / LAG3 IgG4,Kappa
10-858 Mirikizumab (IL23A) Humanized / IL23A [Homo sapiens] IgG4-kappa
21-934 Miromavimab Mus musculus / Rabies Virus Strain ERA GP Ectodomain Epitope G-II IgG1,Kappa
10-757 Mirvetuximab (FOLR1) Chimeric / FOLR1 [Homo sapiens] IgG1-kappa
10-987 Mirzotamab (CD276/B7-H3) Chimeric,Humanized / CD276/B7-H3 [Homo sapiens] IgG1-kappa
10-893 Mitazalimab (CD40/TNFRSF5) Humanized / CD40/TNFRSF5 [Homo sapiens] IgG1-lambda
10-187 Mk-4721 (PSCA) Homo sapiens / PSCA [Homo sapiens] IgG1-kappa
21-935 Modakafusp Humanized / ADPRC IgG4,Kappa
10-577 Modotuximab (EGFR/ERBB1 domain III) Chimeric / EGFR/ERBB1 domain III [Homo sapiens] IgG1-kappa
10-452 Mogamulizumab (CCR4/CD194) Humanized / CCR4/CD194 [Homo sapiens] IgG1-kappa
10-731 Monalizumab (KLRC1/NKG2A/CD159a/CD94) Humanized / KLRC1/NKG2A/CD159a/CD94 [Homo sapiens] IgG4-kappa
10-223 MOR101 (ICAM1/CD54) Homo sapiens / ICAM1/CD54 [Homo sapiens] Fab-nd-nd
10-224 MOR102 (ICAM1/CD54) Homo sapiens / ICAM1/CD54 [Homo sapiens] Fab-G4-nd
10-226 MOR202 (CD38) Homo sapiens / CD38 [Homo sapiens] IgG1-nd
10-326 Morolimumab (RHD/CD240D) Homo sapiens / RHD/CD240D [Homo sapiens] IgG1-nd
10-851 Mosunetuzumab (CD3E/MS4A1/CD20) Humanized / CD3E/MS4A1/CD20 [Homo sapiens] IgG1-kappa
10-089 Motavizumab (RSV) Humanized / RSV [Respiratory syncytial virus] IgG1-kappa
21-866 Moxetumomab    
10-904 Murlentamab (AMHR2) Humanized / AMHR2 [Homo sapiens] IgG1-kappa
10-155 Muromonab-Cd3 (CD3E) Mus musculus / CD3E [Homo sapiens] IgG2a-kappa
10-330 Nacolomab Tafenatox (MUC1 sialylated CA242) Mus musculus / MUC1 sialylated CA242 [Homo sapiens] Fab-G1-kappa
21-936 Nadecnemab Homo sapiens / GFRA3 IgG4,Kappa
10-453 Namilumab (CSF2/GM-CSF) Homo sapiens / CSF2/GM-CSF [Homo sapiens] IgG1-kappa
10-087 Naptumomab Estafenatox (TPBG) Mus musculus / TPBG [Homo sapiens] Fab-G1-kappa
10-767 Naratuximab (CD37/TSPAN26) Chimeric / CD37/TSPAN26 [Homo sapiens] IgG1-kappa
10-467 Narnatumab (MST1R/CD136) Homo sapiens / MST1R/CD136 [Homo sapiens] IgG1-kappa
10-869 Narsoplimab (MASP2) Homo sapiens / MASP2 [Homo sapiens] IgG4-lambda
10-090 Natalizumab (ITGA4/CD49d) Humanized / ITGA4/CD49d [Homo sapiens] IgG4-kappa
10-762 Navicixizumab (DLL4/VEGFA) Chimeric,Humanized / DLL4/VEGFA [Homo sapiens] IgG2-kappa
10-698 Navivumab (Influenza A virus hemagglutinin HA) Homo sapiens / Influenza A virus hemagglutinin HA [Influenza A virus] IgG1-kappa
10-932 Naxitamab (Ganglioside GD2) Chimeric / Ganglioside GD2 [Homo sapiens] IgG1-kappa
10-229 Nebacumab (Endotoxin) Homo sapiens / Endotoxin [Gram negative bacteria] IgM-kappa
10-310 Necitumumab (EGFR/ERBB1 ) Homo sapiens / EGFR/ERBB1 [Homo sapiens] IgG1-kappa
10-689 Nemolizumab (IL31RA) Humanized / IL31RA [Homo sapiens] IgG2-kappa
10-583 Nesvacumab (ANGPT2) Homo sapiens / ANGPT2 [Homo sapiens] IgG1-nd
10-876 Netakimab (IL17A) Homo sapiens,Chimeric / IL17A [Homo sapiens] IgG1-kappa
10-960 Nidanilimab (IL1RAP) Humanized / IL1RAP [Homo sapiens] IgG1-kappa
10-955 Nimacimab (CNR1) Humanized / CNR1 [Homo sapiens] IgG4-kappa
10-091 Nimotuzumab (EGFR) Humanized / EGFR [Homo sapiens] IgG1-kappa
21-937 Nipocalimab Homo sapiens / FCGRT IgG1,Lambda
10-913 Nirsevimab (RSV) Humanized / RSV [Homo sapiens] IgG1-kappa
21-938 Nivatrotamab Humanized / GD2, CD3E Bispecific Mixed mAb and scFv IgG1;naKappa;Kappa
10-496 Nivolumab (PDCD1/PD1/CD279) Homo sapiens / PDCD1/PD1/CD279 [Homo sapiens] IgG4-kappa
10-989 Nurulimab (CTLA4) Homo sapiens / CTLA4 [Homo sapiens] IgG1-kappa
10-674 Obexelimab (CD19) Chimeric / CD19 [Homo sapiens] IgG1-kappa
10-697 Obiltoxaximab (Anthrax protective antigen) Chimeric / Anthrax protective antigen [Bacillus anthracis] IgG1-kappa
10-260 Obinutuzumab (MS4A1/CD20) Humanized / MS4A1/CD20 [Homo sapiens] IgG1-kappa
21-939 Obrindatamab Humanized / CD276, CD3E Bispecific scFv with Domain Crossover,Kappa;Lambda
10-497 Ocaratuzumab (MS4A1/CD20) Humanized / MS4A1/CD20 [Homo sapiens] IgG1-kappa
21-940 Ociperlimab Humanized / TIGIT IgG1,Kappa
10-249 Ocrelizumab (MS4A1/CD20) Humanized / MS4A1/CD20 [Homo sapiens] IgG1-nd
10-990 Odesivimab (Zaire Ebola virus) Homo sapiens / Zaire Ebola virus [Zaire ebolavirus] IgG1-kappa
10-991 Odronextamab (CD3E) Homo sapiens / CD3E [Homo sapiens] IgG4-kappa
10-157 Odulimomab (ITGAL/CD11a) Mus musculus / ITGAL/CD11a [Homo sapiens] F(ab')2-G1-nd
10-230 Ofatumumab (MS4A1/CD20) Homo sapiens / MS4A1/CD20 [Homo sapiens] IgG1-kappa
10-439 Olaratumab (PDGFRA/PDGFR2/CD140a) Homo sapiens / PDGFRA/PDGFR2/CD140a [Homo sapiens] IgG1-kappa
10-838 Oleclumab (NT5E/CD37) Homo sapiens / NT5E/CD37 [Homo sapiens] IgG1-lambda
11-052 Olendalizumab (C5) Humanized / C5 [Homo sapiens] IgG2-G4-kappa
10-902 Olinvacimab (KDR/VEGFR2) Humanized / KDR/VEGFR2 [Homo sapiens] IgG1-kappa-lambda
10-440 Olokizumab (IL6) Humanized / IL6 [Homo sapiens] IgG4-kappa
10-092 Omalizumab (IGHE) Humanized / IGHE [Homo sapiens] IgG1-kappa
10-915 Omburtamab (CD276/B7-H3/B7RP-2) Mus musculus / CD276/B7-H3/B7RP-2 [Homo sapiens] IgG1-kappa
21-941 Omodenbamab Homo sapiens / SpA IgG3,Kappa
10-454 Onartuzumab (MET/RCCP2) Humanized / MET/RCCP2 [Homo sapiens] Fab-G1-kappa -[Fc-G1]
10-180 Oncolym (HLA-DR10) Mus musculus / HLA-DR10 [Homo sapiens] IgG2a-nd
21-942 Onfekafusp Homo sapiens / FN extra domain B Kappa
21-943 Ongericimab Humanized / PCSK9 IgG4,Kappa
10-873 Ontamalimab (MADCAM1) Homo sapiens / MADCAM1 [Homo sapiens] IgG2-kappa
10-656 Ontuxizumab (CD248) Chimeric,Humanized / CD248 [Homo sapiens] IgG1-kappa
10-892 Onvatilimab (VSIR) Homo sapiens / VSIR [Homo sapiens] IgG1-kappa
10-726 Opicinumab (LINGO1/LRRN6A/LERN1) Homo sapiens / LINGO1/LRRN6A/LERN1 [Homo sapiens] IgG1-kappa
10-259 Oportuzumab Monatox (EPCAM/CD326) Humanized / EPCAM/CD326 [Homo sapiens] scFv-kappa-heavy
21-944 Opucolimab Humanized / PDL1 IgG1,Lambda
10-159 Oregovomab (MUC16/CA125) Mus musculus / MUC16/CA125 [Homo sapiens] IgG1-kappa
10-914 Orilanolimab (FCGRT) Chimeric / FCGRT [Homo sapiens] IgG4-kappa
10-498 Orticumab (oxLDL) Homo sapiens / oxLDL [Homo sapiens] IgG1-lambda
10-917 Osocimab (F11) Homo sapiens / F11 [Homo sapiens] IgG1-kappa
10-231 OST 577 (HBV) Homo sapiens / HBV [Hepatitis B virus]  
10-257 Otelixizumab (CD3E) Chimeric,Humanized / CD3E [Homo sapiens] IgG1-lambda
10-225 Otilimab (CSF2/GM-CSF) Homo sapiens / CSF2/GM-CSF [Homo sapiens] IgG1-lambda
10-653 Otlertuzumab (CD37/TSPAN26) Humanized / CD37/TSPAN26 [Homo sapiens] VH-V-kappa-CH2-CH3
24-429 OX40L Antibody [R4930 (Oxelumab)], Human IgG1 Oxelumab binds to human OX40L, the ligand of OX40,  stimulatory receptor that is expressed on activated T cells, natural killer (NK) cells and natural killer T (NKT) cells. IgG1 kappa
24-430 OX40L Antibody [R4930 (Oxelumab)], Rabbit IgG Oxelumab binds to human OX40L, the ligand of OX40,  stimulatory receptor that is expressed on activated T cells, natural killer (NK) cells and natural killer T (NKT) cells. IgG kappa
10-441 Oxelumab (TNFSF4/CD252) Homo sapiens / TNFSF4/CD252 [Homo sapiens] IgG1-kappa
10-585 Ozanezumab (RTN4/NOGO) Humanized / RTN4/NOGO [Homo sapiens] IgG1-nd
10-468 Ozoralizumab (ALB/TNFSF2/TNF-alpha/TNFA ) Humanized / ALB/TNFSF2/TNF-alpha/TNFA [Homo sapiens] VH-VH'-VH
21-945 Pacanalotamab Humanized / TNFRSF17, CD3E Bispecific scFv,Kappa;Lambda
10-992 Pacmilimab (CD274/PD-L1/B7-H1) Homo sapiens / CD274/PD-L1/B7-H1 [Homo sapiens] IgG4-kappa
10-271 Pagibaximab (Staphylococcus epidermidis lipoteichoic acid) Chimeric / Staphylococcus epidermidis lipoteichoic acid [Staphylococcus epidermidis] IgG1-kappa
10-094 Palivizumab (RSV) Humanized / RSV [Respiratory syncytial virus] IgG1-kappa
10-723 Pamrevlumab (CTGF/IGFBP-8) Homo sapiens / CTGF/IGFBP-8 [Homo sapiens] IgG1-kappa
10-232 Panitumumab (EGFR) Homo sapiens / EGFR [Homo sapiens] IgG2-kappa
10-264 Panobacumab (Serotype IATS O12) Homo sapiens / Serotype IATS O12 [Pseudomonas aeruginosa, Gram negative bacteria] IgM-kappa
10-499 Parsatuzumab (EGFL7) Humanized / EGFL7 [Homo sapiens] IgG1-kappa
10-124 Pascolizumab (IL4) Humanized / IL4 [Homo sapiens] IgG1-kappa
10-663 Pasotuxizumab (CD3E/FOLH1) Chimeric,Humanized / CD3E/FOLH1 [Homo sapiens] (scFv-heavy-kappa)-(scFv-heavy-lambda)
10-469 Pateclizumab (LTA/TNFSF1) Humanized / LTA/TNFSF1 [Homo sapiens] IgG1-kappa
10-482 Patritumab (ERBB3) Homo sapiens / ERBB3 [Homo sapiens] IgG1-kappa
21-946 Pavunalimab Humanized / LAG3, CTLA4 Bispecific ,IgG1,Kappa
21-947 Pavurutamab Humanized / TNFRSF17, CD3E Bispecific scFv,Kappa;Lambda
21-948 Pelgifatamab Homo sapiens / FOLH1 IgG1,Kappa
10-615 Pembrolizumab (PDCD1/PD1/CD279) Humanized / PDCD1/PD1/CD279 [Homo sapiens] IgG4-kappa
21-949 Penpulimab Humanized / PDCD1 IgG1,Kappa
10-696 Pepinemab (SEMA4D) Chimeric,Humanized / SEMA4D [Homo sapiens] IgG4-kappa
10-572 Perakizumab (IL17A) Humanized / IL17A [Homo sapiens] IgG1-kappa
10-095 Pertuzumab (ERBB2/EGFR2/CD340) Humanized / ERBB2/EGFR2/CD340 [Homo sapiens] IgG1-kappa
10-994 Petosemtamab (EGFR/ERBB1/LGR5) Homo sapiens / EGFR/ERBB1/LGR5 [Homo sapiens] IgG1-kappa
10-096 Pexelizumab (C5) Humanized / C5 [Homo sapiens] scFv-nd-nd
10-584 Pidilizumab (PDCD1/CD279) Humanized / PDCD1/CD279 [Homo sapiens] IgG1-kappa
21-950 Pimivalimab Homo sapiens / PDCD1 IgG4,Kappa
21-951 Pimurutamab Humanized / EGFR IgG1,Kappa
10-588 Pinatuzumab Vedotin (CD22) Humanized / CD22 [Homo sapiens] IgG1-kappa
10-573 Placulumab (TNFSF2/TNF-alpha/TNFA) Homo sapiens / TNFSF2/TNF-alpha/TNFA [Homo sapiens] [V-kappa]2-Fc
10-952 Plamotamab (CD3E/MS4A1) Chimeric,Humanized / CD3E/MS4A1 [Homo sapiens] IgG1-kappa / scFv-h-CH2-CH3
21-953 Plonmarlimab Humanized / CSF2 IgG1,Kappa
10-734 Plozalizumab (CCR2/CD192) Humanized / CCR2/CD192 [Homo sapiens] IgG1-kappa
24-536 Podoplanin (MAP tag) Antibody [PMab-1], Rabbit IgG This antibody was raised by immunising rats with 14-residue synthetic peptide mpp3851, which corresponds to amino acids 38-51 (GDGMVPPGIEDKIT) of the platelet-aggregation-stimulating (PLAG) domain of mouse podoplanin. Spleen cells were then harvested, and fused to P3U1 cells to generate stable hybridomas. IgG kappa
24-537 Podoplanin (MAP tag) Antibody [PMab-1], Rat IgG2a This antibody was raised by immunising rats with 14-residue synthetic peptide mpp3851, which corresponds to amino acids 38-51 (GDGMVPPGIEDKIT) of the platelet-aggregation-stimulating (PLAG) domain of mouse podoplanin. Spleen cells were then harvested, and fused to P3U1 cells to generate stable hybridomas. IgG2a kappa
10-589 Polatuzumab Vedotin (CD79B) Humanized / CD79B [Homo sapiens] IgG1-kappa
10-456 Ponezumab (APP Abeta40) Humanized / APP Abeta40 [Homo sapiens] IgG2-kappa
21-952 Ponsegromab Humanized / GDF15 IgG1,Kappa
10-836 Porgaviximab (Zaire Ebola virus) Chimeric / Zaire Ebola virus [Zaire ebolavirus] IgG1-kappa
10-937 Pozelimab (C5) Homo sapiens / C5 [Homo sapiens] IgG4-kappa
10-995 Praluzatamab (ALCAM/CD166) Humanized / ALCAM/CD166 [Homo sapiens] IgG1-kappa
10-860 Prasinezumab (SNCA) Humanized / SNCA [Homo sapiens] IgG1-kappa
10-763 Prezalumab (ICOSLG/B7-H2/B7RP-1/CD275) Homo sapiens / ICOSLG/B7-H2/B7RP-1/CD275 [Homo sapiens] IgG2-kappa
10-181 Priliximab (CD4) Chimeric / CD4 [Homo sapiens] IgG1-kappa
10-590 Pritoxaximab (shiga toxin type 1 B subunit) Chimeric / shiga toxin type 1 B subunit [Escherichia coli] IgG1-kappa
10-285 Pritumumab (VIM ) Homo sapiens / VIM [Homo sapiens] IgG1-nd
10-916 Prolgolimab (PDCD1/PD1/CD279) Homo sapiens,Chimeric / PDCD1/PD1/CD279 [Homo sapiens] IgG1-kappa-lambda
21-954 Pucotenlimab Chimeric / PDCD1 IgG4,Kappa
21-955 Quavonlimab Humanized / CTLA4 IgG1,Kappa
10-961 Quetmolimab (CX3CL1) Chimeric,Humanized / CX3CL1 [Homo sapiens] IgG2-kappa
10-481 Quilizumab (IGHE) Humanized / IGHE [Homo sapiens] IgG1-kappa
10-247 Racotumomab (Idiotope of anti-(N-glycolylneuraminic acid (NeuGc,NGNA) -gangliosides GM3) Mus musculus IgM-kappa monoclonal antibody P3) Mus musculus / Idiotope of anti-(N-glycolylneuraminic acid (NeuGc,NGNA) -gangliosides GM3) Mus musculus IgM-kappa monoclonal antibody P3 [Homo sapiens] IgG1-kappa
10-457 Radretumab (FN EDB) Homo sapiens / FN EDB [Homo sapiens] [(scFv-heavy-kappa)-IGHE-CH4]2
10-126 Rafivirumab (RV) Homo sapiens / RV [Rabies virus] IgG1-lambda
21-956 Ragifilimab Humanized / TNFRSF18 IgG1,Kappa
10-642 Ralpancizumab (PCSK9/NARC1/ PC9) Humanized / PCSK9/NARC1/ PC9 [Homo sapiens] IgG2-kappa
10-311 Ramucirumab (KDR/CD309) Homo sapiens / KDR/CD309 [Homo sapiens] IgG1-kappa
10-802 Ranevetmab (NGF/NGFB) Caninized / NGF/NGFB [Mus musculus] IgG1-kappa
10-098 Ranibizumab (VEGFA) Humanized / VEGFA [Homo sapiens] Fab-G1-kappa
10-888 Ravagalimab (CD40/TNFRSF) Humanized / CD40/TNFRSF [Homo sapiens] IgG1-kappa
10-813 Ravulizumab (C5) Humanized / C5 [Homo sapiens] IgG2-G4-kappa
10-277 Raxibacumab (Anthrax protective antigen ) Homo sapiens / Anthrax protective antigen [Bacillus anthracis] IgG1-lambda
21-957 Recaticimab Humanized / PCSK9 IgG1,Kappa
10-756 Refanezumab (MAG/SIGLEC-4A) Humanized / MAG/SIGLEC-4A [Homo sapiens] IgG1-kappa
10-233 Regavirumab (HCMV) Homo sapiens / HCMV [Human herpesvirus 6] IgG1-kappa
10-870 Relatlimab (LAG3/CD223) Homo sapiens / LAG3/CD223 [Homo sapiens] IgG4-kappa
10-958 Relfovetmab (NGF/NGFB) Felinized / NGF/NGFB [Felis catus] IgG1-kappa
10-673 Remtolumab (IL17A/TNFSF2/TNF-alpha/TNFA) Homo sapiens / IL17A/TNFSF2/TNF-alpha/TNFA [Homo sapiens] [VH-VH'-H-Gamma1-VL-VL'-C-kappa]-dimer
10-291 Reslizumab (IL5) Humanized / IL5 [Homo sapiens] IgG4-nd
10-997 Retifanlimab (PDCD1/PD1/CD279) Chimeric,Humanized / PDCD1/PD1/CD279 [Homo sapiens] IgG4-kappa
21-959 Revdofilimab Chimeric / TNFRSF4 IgG1,Kappa
10-317 Rilotumumab (HGF) Homo sapiens / HGF [Homo sapiens] IgG2-kappa
10-742 Rinucumab (PDGFRB/ PDGFR-1/CD140b) Homo sapiens / PDGFRB/ PDGFR-1/CD140b [Homo sapiens] IgG4-kappa
21-960 Ripertamab Chimeric / MS4A1 IgG1,Kappa
10-735 Risankizumab (IL23A) Humanized / IL23A [Homo sapiens] IgG1-kappa
10-182 Rituximab (MS4A1) Chimeric / MS4A1 [Homo sapiens] IgG1-kappa
10-761 Rivabazumab (PcrV) Humanized / PcrV [Pseudomonas aeruginosa,Gram negative bacteria] Fab'-G1-kappa
10-312 Robatumumab (IGF1R/CD221 ) Homo sapiens / IGF1R/CD221 [Homo sapiens] IgG1-kappa
10-442 Roledumab (RHD) Homo sapiens / RHD [Homo sapiens] IgG1-kappa
10-918 Rolinsatamab (PRLR) Chimeric / PRLR [Homo sapiens] IgG1-kappa
10-879 Romilkimab (IL13/IL4) Chimeric,Humanized / IL13/IL4 [Homo sapiens] [VH-VH'-H-Gamma1-VL-VL'-C-kappa]-dimer
10-479 Romosozumab (SOST) Humanized / SOST [Homo sapiens] IgG2-kappa
10-340 Rontalizumab (IFNA1) Humanized / IFNA1 [Homo sapiens] IgG1-kappa
10-799 Rosmantuzumab (RSPO3) Humanized / RSPO3 [Homo sapiens] IgG1-kappa
21-961 Rosopatamab Chimeric / FOLH1 IgG1,Kappa
10-738 Rovalpituzumab (DLL3) Humanized / DLL3 [Homo sapiens] IgG1-kappa
10-319 Rovelizumab (ITGAL/CD11a/ITGB2/CD18) Humanized / ITGAL/CD11a/ITGB2/CD18 [Homo sapiens] IgG4-nd
10-781 Rozanolixizumab (FCGRT) Chimeric,Humanized / FCGRT [Homo sapiens] IgG4-kappa
24-493 RSV Antibody [RSHZ19 (Felvizumab)], Human IgG1 This antibody was prepared by the humanization of  an F protein-specific murine MAb, RSV19. More specifically, molecular techniques were used to insert the complementarity determining regions from murine RSV19 into a human IgG1 heavy and k light chain-variable domain framework. IgG1 kappa
24-494 RSV Antibody [RSHZ19 (Felvizumab)], Rabbit IgG This antibody was prepared by the humanization of  an F protein-specific murine MAb, RSV19. More specifically, molecular techniques were used to insert the complementarity determining regions from murine RSV19 into a human IgG1 heavy and k light chain-variable domain framework. IgG kappa
21-865 RSV-neutralizing Human (Am14) Humanized / Respipatory syncytial virus Human IgG1
21-864 RSV-neutralizing Human (D25) Humanized / Respipatory syncytial virus Human IgG1
21-962 Runimotamab Humanized / ERBB2, CD3E Bispecific IgG1;Kappa;Kappa
10-066 Ruplizumab (CD40LG) Humanized / CD40LG [Homo sapiens] IgG1-kappa
21-963 Sabatolimab Humanized / HAVCR2 IgG4,Kappa
10-800 Sacituzumab (TACSTD2) Humanized / TACSTD2 [Homo sapiens] IgG1-kappa
10-443 Samalizumab (CD200) Humanized / CD200 [Homo sapiens] IgG2-G4-kappa
10-898 Samrotamab (LRRC15) Chimeric,Humanized / LRRC15 [Homo sapiens] IgG1-kappa
10-475 Sarilumab (IL6R/CD126) Homo sapiens / IL6R/CD126 [Homo sapiens] IgG1-kappa
10-998 Sasanlimab (PDCD1/PD1/CD279) Humanized / PDCD1/PD1/CD279 [Homo sapiens] IgG4-kappa
11-053 Satralizumab (IL6R) Humanized / IL6R [Homo sapiens] IgG2-kappa
10-161 Satumomab (TAG-72) Mus musculus / TAG-72 [Homo sapiens] IgG1-kappa
10-339 Secukinumab (IL17A) Homo sapiens / IL17A [Homo sapiens] IgG1-kappa
10-832 Selicrelumab (CD40/TNFRSF5) Homo sapiens / CD40/TNFRSF5 [Homo sapiens] IgG2-kappa
10-956 Semorinemab (MAPT) Chimeric,Humanized / MAPT [Homo sapiens] IgG4-kappa
10-940 Serclutamab (EGFR) Chimeric,Humanized / EGFR [Homo sapiens] IgG1-kappa
10-586 Seribantumab (ERBB3) Homo sapiens / ERBB3 [Homo sapiens] IgG2-lambda
10-999 Serplulimab (PDCD1/PD1/CD279) Humanized / PDCD1/PD1/CD279 [Homo sapiens] IgG4-kappa
10-591 Setoxaximab (Stx2/SLT-II) Chimeric / Stx2/SLT-II [Escherichia coli] IgG1-kappa
10-778 Setrusumab (SOST) Homo sapiens / SOST [Homo sapiens] IgG2-lambda
10-097 Sevirumab (HCMV) Homo sapiens / HCMV [Human herpesvirus 6] IgG1-kappa
21-964 Sibeprenlimab Humanized / TNFSF13 IgG2,Kappa
10-296 Sibrotuzumab (FAP) Humanized / FAP [Homo sapiens] IgG1-kappa
10-335 Sifalimumab (IFNA1) Homo sapiens / IFNA1 [Homo sapiens] IgG1-kappa
10-313 Siltuximab (IL6) Chimeric / IL6 [Homo sapiens] IgG1-kappa
10-574 Simtuzumab (LOXL2) Humanized / LOXL2 [Homo sapiens] IgG4-kappa
10-919 Sintilimab (PDCD1/PD1/CD279) Homo sapiens / PDCD1/PD1/CD279 [Homo sapiens] IgG4-kappa
10-088 Siplizumab (CD2/LFA-2) Humanized / CD2/LFA-2 [Homo sapiens] IgG1-kappa
10-846 Sirtratumab (SLITRK6) Homo sapiens / SLITRK6 [Homo sapiens] IgG2-kappa
10-470 Sirukumab (IL6 ) Homo sapiens / IL6 [Homo sapiens] IgG1-kappa
10-632 Sofituzumab Vedotin (MUC16/CA125) Humanized / MUC16/CA125 [Homo sapiens] IgG1-kappa
10-314 Solanezumab (APP Abeta,soluble monomer) Humanized / APP Abeta,soluble monomer [Homo sapiens] IgG1-kappa
10-480 Solitomab (CD3E/EpCAM) Mus musculus / CD3E/EpCAM [Homo sapiens] (scFv-kappa-heavy)-(scFv-heavy-kappa)
11-000 Sonelokimab (ALB,IL17A) Humanized / ALB,IL17A [Homo sapiens] VH-VH'-VH
10-269 Sontuzumab (MUC1/CD227) Humanized / MUC1/CD227 [Homo sapiens] IgG1-nd
21-965 Sotigalimab Humanized / CD40 IgG1,Kappa
21-966 Sotrovimab Homo sapiens / SARS-CoV-2 Spike RBD IgG1,Kappa
21-878 Sotrovimab (VIR-7831/GSK4182136)  Humanized / Spike glycoprotein [SARS-CoV-2] Human IgG
10-852 Spartalizumab (PDCD1/PD1/CD279) Humanized / PDCD1/PD1/CD279 [Homo sapiens] IgG4-kappa
10-920 Spesolimab (IL36RN) Chimeric,Humanized / IL36RN [Homo sapiens] IgG1-kappa
10-228 Stamulumab (MSTN/GDF-8) Homo sapiens / MSTN/GDF-8 [Homo sapiens] IgG1-nd
21-967 Sudubrilimab Humanized / CD274 IgG1,Kappa
21-968 Sugemalimab Homo sapiens / PDL1 IgG4,Lambda
10-162 Sulesomab (NCA-90) Mus musculus / NCA-90 [Homo sapiens] Fab'-G1-nd
10-777 Suptavumab (RSV glycoprotein F) Homo sapiens / RSV glycoprotein F [Respiratory syncytial virus] IgG1-kappa
21-969 Surzebiclimab Humanized / HAVCR2 IgG1,Kappa
10-884 Sutimlimab (C1S) Chimeric,Humanized / C1S [Homo sapiens] IgG4-kappa
10-343 Suvizumab (HIV-1) Humanized / HIV-1 [Human immunodeficiency virus 1] IgG1-kappa
21-851 Suvratoxumab Homo sapiens / alpha toxin [Staphylococcus aureus] IgG1-kappa
10-152 T10B9.1A-31 (T cell receptor) Mus musculus / T cell receptor [Homo sapiens] IgM-kappa
10-471 Tabalumab (TNFSF13B/CD257) Homo sapiens / TNFSF13B/CD257 [Homo sapiens] IgG4-kappa
10-921 Tabituximab (FZD10) Chimeric / FZD10 [Homo sapiens] IgG1-kappa
10-130 Tadocizumab (ITGA2B_ITGB3) Humanized / ITGA2B_ITGB3 [Homo sapiens] Fab-G1-kappa
10-676 Tafasitamab (CD19) Humanized / CD19 [Homo sapiens] IgG1-G2-kappa
11-001 Tafolecimab (PCSK9) Homo sapiens / PCSK9 [Homo sapiens] IgG2-kappa
24-641 TAG-72 Antibody [Minretumomab (CC49 )], Mouse IgG1 This antibody was raised by immunising BALB/c mice with TAG-72 purified from LS-174T human carcinoma xenograft. IgG1 kappa
24-642 TAG-72 Antibody [Minretumomab (CC49 )], Rabbit IgG This antibody was raised by immunising BALB/c mice with TAG-72 purified from LS-174T human carcinoma xenograft. IgG kappa
10-845 Talacotuzumab (CD123/IL3Ra) Homo sapiens / CD123/IL3Ra [Homo sapiens] IgG2-kappa
21-867 Talizumab Chimeric, Humanized / IgE IgG4-kappa-lambda
10-286 Talizumab (CD3E/GPRC5D) Chimeric,Humanized / CD3E/GPRC5D [Homo sapiens] IgG4-kappa-lambda
10-942 Tamrintamab (DPEP3) Homo sapiens,Chimeric / DPEP3 [Homo sapiens] IgG4-lambda
10-252 Tanezumab (IGHE) Humanized / IGHE [Homo sapiens] IgG1-nd
10-598 Tarextumab (CD52) Caninized / CD52 [Homo sapiens] IgG2-kappa-lambda
21-970 Tarlatamab Humanized / DLL3, CD3E Bispecific scFv;Kappa;Lambda
11-013 Tavolimab (TNF- SF4 receptor I) Homo sapiens / TNF- SF4 receptor I [Homo sapiens] TBP-1:tumor necrosis factor (TNF) binding protein variant 1
21-971 Tebentafusp Humanized / CD3E Kappa
21-972 Tebotelimab Humanized / PDCD1, LAG3 Bispecific scFv ,IgG4;Kappa;Kappa
10-156 Technetium (99Mtc) Nofetumomab Merpentan (IL3RA/CD123) Humanized / IL3RA/CD123 [Homo sapiens] IgG1-kappa
10-935 Teclistamab (MS4A1) Mus musculus / MS4A1 [Homo sapiens] Fab-G2b-kappa
10-163 Tecnemab  (CSPG4/HMW-MAA/CD3E/ERBB2) Mus musculus,Humanized / CSPG4/HMW-MAA/CD3E/ERBB2 [Homo sapiens],toxin [Clostridium perfringens] F(ab')2, Fab / Fab2 mix, IgG1-nd, F(ab')2-G1-kappa
10-278 Tefibazumab (Fibrin-binding surface epitope clumping factor A) Humanized / Fibrin-binding surface epitope clumping factor A [Staphylococcus aureus] IgG1-kappa
21-973 Telazorlimab Humanized / TNFRSF4 IgG1,Kappa
10-333 Telimomab Aritox (CD5 ) Mus musculus / CD5 [Homo sapiens] Fab-nd-nd
10-793 Telisotuzumab (MET/RCCP2) Humanized / MET/RCCP2 [Homo sapiens] IgG1-kappa
10-248 Tenatumomab (TNC/HXB) Mus musculus / TNC/HXB [Homo sapiens] IgG2b-nd
10-289 Teneliximab (CD40/TNFRSF5) Chimeric / CD40/TNFRSF5 [Homo sapiens] IgG1-nd
11-015 Teplizumab (CD3)    
10-894 Tepoditamab (CD3E/CLEC12A) Homo sapiens / CD3E/CLEC12A [Homo sapiens] IgG1-kappa
10-348 Teprotumumab (IGF1R/CD221) Homo sapiens / IGF1R/CD221 [Homo sapiens] IgG1-nd
10-686 Tesidolumab (C5) Homo sapiens / C5 [Homo sapiens] IgG1-lambda
21-974 Tesnatilimab Homo sapiens / KLRK1 IgG4,Kappa
10-741 Tezepelumab (TSLP) Homo sapiens / TSLP [Homo sapiens] IgG2-lambda
10-867 Tibulizumab (IL17A/TNFSF13B/CD257) Humanized / IL17A/TNFSF13B/CD257 [Homo sapiens] IgG4-kappa-[scFv]2
10-954 Tidutamab (CD3 epsilon/SSTR2) Chimeric,Humanized / CD3 epsilon/SSTR2 [Homo sapiens] IgG1-kappa / scFv-h-CH2-CH3
10-256 Tigatuzumab (TNFRSF10B/CD262) Humanized / TNFRSF10B/CD262 [Homo sapiens] IgG1-nd
10-747 Tilavonemab (MAPT) Chimeric / MAPT [Homo sapiens] IgG4-kappa
10-581 Tildrakizumab (IL23A) Humanized / IL23A [Homo sapiens] IgG1-kappa
21-975 Tilogotamab Humanized / TNFRSF10B IgG1,Kappa
11-003 Tilvestamab (PCSK9) Humanized / PCSK9 [Homo sapiens] IgG1-kappa
10-841 Timigutuzumab (ERBB2/EGFR2/CD340) Humanized / ERBB2/EGFR2/CD340 [Homo sapiens] IgG1-kappa
10-770 Timolumab (AOC3/VAP1) Homo sapiens / AOC3/VAP1 [Homo sapiens] IgG4-kappa
11-004 Tinurilimab (CEACAM6) Humanized / CEACAM6 [Homo sapiens] IgG1-kappa
10-856 Tiragolumab (TIGIT/VSIG9/VSTM3) Homo sapiens / TIGIT/VSIG9/VSTM3 [Homo sapiens] IgG1-kappa